Monica Casucci

3.9k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Monica Casucci is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Monica Casucci has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 16 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Monica Casucci's work include CAR-T cell therapy research (31 papers), Immune Cell Function and Interaction (12 papers) and Virus-based gene therapy research (10 papers). Monica Casucci is often cited by papers focused on CAR-T cell therapy research (31 papers), Immune Cell Function and Interaction (12 papers) and Virus-based gene therapy research (10 papers). Monica Casucci collaborates with scholars based in Italy, United States and United Kingdom. Monica Casucci's co-authors include Attilio Bondanza, Chiara Bonini, Fabio Ciceri, Laura Falcone, Barbara Camisa, Margherita Norelli, Claudio Bordignon, Maurilio Ponzoni, Catia Traversari and Francesca Sanvito and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Monica Casucci

34 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

2018 997 citations Margherita Norelli, Barbara Camisa et al. Nature Medicine profile →

Peers

Countries citing papers authored by Monica Casucci

Since Specialization

Citations

This map shows the geographic impact of Monica Casucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Casucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Casucci more than expected).

Fields of papers citing papers by Monica Casucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Casucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Casucci. The network helps show where Monica Casucci may publish in the future.

Co-authorship network of co-authors of Monica Casucci

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Casucci. A scholar is included among the top collaborators of Monica Casucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Casucci. Monica Casucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus 2024 ·Nature Communications ·Matteo Doglio, Alessio Ugolini, (unknown), Barbara Camisa, T. Constantin, (unknown), Stefano Rosso, Raffaella Greco, Fabio Ciceri, Francesca Sanvito, Monica Casucci, Angelo A. Manfredi, Chiara Bonini	42
2	CAR T cells in solid tumors and metastasis: paving the way forward 2024 ·Cancer and Metastasis Reviews ·(unknown), (unknown), (unknown), Monica Casucci	5
3	CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Silvia Arcangeli, Laura Falcone, Barbara Camisa, (unknown), Béatrice Gréco, (unknown), Alice Bergamini, Attilio Bondanza, Fabio Ciceri, Chiara Bonini, Monica Casucci	30
4	Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 2023 ·Frontiers in Oncology ·Fabio Giglio, (unknown), Francesca Lorentino, Maddalena Noviello, Elisabetta Xue, Raffaella Greco, (unknown), Alessandro Bruno, Maria Teresa Lupo Stanghellini, Matteo Giovanni Carrabba, Roberta La Starza, Monica Casucci, Chiara Bonini, Sabina Chiaretti, Jacopo Peccatori, Robin Foà, Fabio Ciceri	0
5	Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy 2022 ·Journal of Experimental & Clinical Cancer Research ·Cristina Chiriaco, (unknown), (unknown), Stefano Ughetto, Chiara Modica, Ilaria Martinelli, (unknown), Letizia Vitali, (unknown), Monica Casucci, (unknown), Silvia Giordano, Dario Sangiolo, Valeria Leuci, Elisa Vigna	15
6	Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses 2021 ·EMBO Molecular Medicine ·Adele Mucci, Gabriele Antonarelli, (unknown), (unknown), Giacomo Desantis, (unknown), Béatrice Gréco, Monica Casucci, Giulia Escobar, Laura Passerini, Nico Lachmann, Francesca Sanvito, Matteo Barcella, Ivan Merelli, Luigi Naldini, Bernhard Gentner	20
7	Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 2021 ·Nature Communications ·(unknown), C Garavaglia, Andrea Grilli, Claudia de Lalla, Alessandra Mancino, Lucia Mori, Gennaro De Libero, Daniela Montagna, Monica Casucci, Marta Serafini, Chiara Bonini, Daniel Häußinger, Fabio Ciceri, Massimo Bernardi, Sara Mastaglio, Silvio Bicciato, Paolo Dellabona, Giulia Casorati	7
8	Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer 2021 ·Human Gene Therapy ·Anna Stornaiuolo, Barbara Valentinis, (unknown), Cinzia Scavullo, Claudia Asperti, Dan Zhou, Yeny Martinez de la Torre, (unknown), Monica Casucci, Simona Porcellini, Catia Traversari	18
9	Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients 2020 ·Frontiers in Immunology ·Silvia Arcangeli, Laura Falcone, Barbara Camisa, (unknown), (unknown), Fabio Giglio, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci	96
10	Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene 2018 ·Frontiers in Immunology ·Monica Casucci, Laura Falcone, Barbara Camisa, Margherita Norelli, Simona Porcellini, Anna Stornaiuolo, Fabio Ciceri, Catia Traversari, Claudio Bordignon, Chiara Bonini, Attilio Bondanza	72
11	Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells breakdown → 2018 ·Nature Medicine ·Margherita Norelli, Barbara Camisa, Giulia Barbiera, Laura Falcone, (unknown), Marco Genua, Francesca Sanvito, Maurilio Ponzoni, Claudio Doglioni, Patrizia Cristofori, Catia Traversari, Claudio Bordignon, Fabio Ciceri, Renato Ostuni, Chiara Bonini, Monica Casucci, Attilio Bondanza	997
12	Combining De-Glycosylating Agents with CAR-T Cells for Targeting Solid Tumors and Reducing Toxicity 2018 ·Blood ·Béatrice Gréco, (unknown), Barbara Camisa, (unknown), Laura Falcone, Andrea Graziani, Chiara Bonini, Attilio Bondanza, Monica Casucci	3
13	Exploiting Secreted Luciferases to Monitor Tumor Progression In Vivo 2016 ·Methods in molecular biology ·Laura Falcone, Monica Casucci	8
14	Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 2016 ·Human Gene Therapy ·Maria Caterina Rotiroti, Silvia Arcangeli, Monica Casucci, Vincenzo Maria Perriello, Attilio Bondanza, Andrea Biondi, Sarah Tettamanti, Ettore Biagi	17
15	Clinical pharmacology of CAR-T cells: Linking cellular pharmacodynamics to pharmacokinetics and antitumor effects 2015 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Margherita Norelli, Monica Casucci, Chiara Bonini, Attilio Bondanza	28
16	Overcoming the toxicity hurdles of genetically targeted T cells 2014 ·Cancer Immunology Immunotherapy ·Monica Casucci, Robert E. Hawkins, Gianpietro Dotti, Attilio Bondanza	48
17	Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene 2013 ·Molecular Therapy ·Monica Casucci, Serena Perna, Laura Falcone, Barbara Camisa, Zulma Magnani, Massimo Bernardi, Alessandro Crotta, Cristina Tresoldi, Katharina Fleischhauer, Maurilio Ponzoni, Silvia Gregori, F. Caligaris Cappio, Fabio Ciceri, Claudio Bordignon, Alessandro Cignetti, Attilio Bondanza, Chiara Bonini	17
18	CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma 2013 ·Blood ·Monica Casucci, Benedetta Nicolis di Robilant, Laura Falcone, Barbara Camisa, Margherita Norelli, Pietro Genovese, Bernhard Gentner, Fabiana Gullotta, Maurilio Ponzoni, Massimo Bernardi, Magda Marcatti, Aurore Saudemont, Claudio Bordignon, Barbara Savoldo, Fabio Ciceri, Luigi Naldini, Gianpietro Dotti, Chiara Bonini, Attilio Bondanza	290
19	Genetic engineering of T cells for the immunotherapy of haematological malignancies 2011 ·Tissue Antigens ·Monica Casucci, Attilio Bondanza, Laura Falcone, Elena Provasi, Zulma Magnani, Chiara Bonini	4
20	Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes 2011 ·Journal of Cancer ·Monica Casucci, Attilio Bondanza	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact